MDxHealth SA (MDXH)
(Real Time Quote from BATS)
$2.80 USD
-0.09 (-3.11%)
Updated Jun 13, 2024 02:50 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MDXH 2.80 -0.09(-3.11%)
Will MDXH be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for MDXH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDXH
Agiliti (AGTI) Q4 Earnings Beat Estimates
DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates
MDXH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viatris (VTRS) Beats Q3 Earnings Estimates
Surgery Partners (SGRY) Soars 9.9%: Is Further Upside Left in the Stock?
Pediatrix Medical Group (MD) Lags Q3 Earnings and Revenue Estimates
Other News for MDXH
Mdxhealth to Present at Upcoming Investor Conferences
MDxHealth SA (MDXH) Q1 2024 Earnings Call Transcript
MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q1 2024
MDxHealth SA GAAP EPS of -$0.31, revenue of $19.8M
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed